If you are researching prp injection shoulder, you are probably looking for one clean percentage. The honest answer is that there is no single official success rate. Results vary by the exact shoulder condition, the type of PRP used, and whether success is measured by pain, function, range of movement, or patient satisfaction.

Why the answer is not one simple number

That is because prp injection shoulder is not one single diagnosis. Most of the published evidence focuses on rotator cuff tendinopathy or partial-thickness rotator cuff tears, not every cause of shoulder pain. The AAOS guideline says limited evidence does not support the routine use of platelet-rich plasma for rotator cuff tendinopathy or partial tears, which already tells you the evidence is mixed rather than settled.

A fair way to think about prp injection shoulder success is to ask a better question: success for whom, and for what problem? A patient with a partial-thickness rotator cuff tear is not the same as a patient with frozen shoulder, shoulder arthritis, or a full-thickness tear. That difference matters because study results cannot be lifted out of one diagnosis and pasted onto all shoulder pain.

What the stronger studies suggest

The more encouraging side of the prp injection shoulder evidence comes from partial-thickness rotator cuff tears. A 2022 systematic review and meta-analysis in the Journal of Rehabilitation Medicine included 11 studies with 641 patients and found that PRP improved shoulder function and pain more than placebo at all follow-up points, and more than other conservative treatments at 8–12 weeks and beyond 24 weeks.

One of the clearest percentage-style results in the prp injection shoulder literature comes from a 2021 prospective study on rotator cuff tears. Its reported positive global rating results were 77.9% at 6 months, 71.6% at 1 year, and 68.8% at 2 years. Those figures are useful, but they come from one study population, so they should not be treated as a universal success rate for every shoulder patient.

Why the evidence is still mixed

Still, the prp injection shoulder evidence is not one-way traffic. The AAOS guideline did not give routine support for PRP in rotator cuff tendinopathy or partial tears, and it notes the recommendation is limited because the evidence is low quality, insufficient, or conflicting. That is a strong reminder that promising results and routine recommendation are not the same thing.

That is why prp injection shoulder success should never be reduced to one marketing-friendly number. Even the positive meta-analysis is focused on one subgroup, and broader reviews still describe PRP as promising but in need of more consistent evidence before its role is fully established. In plain terms, there are signs it can help selected patients, but the science has not closed the case.

What success usually means in real life

For patients, prp injection shoulder success usually means something more practical than a journal statistic. It means less pain when reaching overhead, less night pain, better shoulder use, and more confidence with daily activity. Johns Hopkins notes that PRP results are usually most noticeable after several weeks and are not permanent, which fits the wider picture of PRP as a gradual rather than instant treatment.

Whether prp injection shoulder treatment feels worthwhile also depends on your goal. If your main aim is pain reduction in a partial-thickness rotator cuff problem, the evidence looks more encouraging. If you want one treatment that reliably restores full function across every shoulder diagnosis, the current evidence does not support that kind of certainty.

A balanced answer

The most honest answer on prp injection shoulder success rates is that there is no single official percentage for all cases. Some studies report strong patient-reported improvement rates, including roughly 68.8% to 77.9% over 6 months to 2 years in one prospective study, while major guideline bodies still describe the overall evidence as limited for routine use in rotator cuff tendinopathy or partial tears.

In practice, prp injection shoulder may look more promising for carefully selected rotator cuff patients than for shoulder pain in general. That is why diagnosis matters so much. The treatment should be judged against the exact tissue problem, not against a vague idea of “shoulder pain” as one condition.

If you are considering prp injection shoulder, the smartest next step is a proper clinical assessment rather than relying on one headline percentage. Read more from Regenesis or get in touch to discuss your symptoms, your diagnosis, and whether PRP is a sensible option for your shoulder problem.